Posted on 9/17/20
Cantel Medical Reports Results for its Fourth Quarter Fiscal Year 2020
Cantel Medical Corp. (NYSE: CMD) today announced financial results for its fourth quarter ended July 31, 2020.Fourth quarter 2020 net sales were $233.4M, down 2.5% compared . . .
Posted on 9/17/20
WebMD Partnership with Twitter
WebMD and Twitter today announced a partnership that marks the first content collaboration between Twitter and a health care platform.The new partnership will bring more WebMD . . .
Posted on 9/17/20
Johnson & Johnson: For The Very Young To The Very Old
SummaryFor established businesses, dividends and earnings per share (EPS) growth are the primary drivers of total returns on share investments.P/E ratios, or more specifically, changes in . . .
Posted on 9/20/20
Melina Sánchez Montañés, Impact First Investments, Interview with Irad Eichler, CEO at 7Chairs
Irad Eichler is a social entrepreneur who co-founded 7Chairs in 2019. 7Chairs is a teletherapy startup focused on providing emotional support to everyone who is dealing with . . .
Posted on 9/17/20
PWNHealth Receives Significant Growth Investment Led by Spectrum Equity
NEW YORK--(BUSINESS WIRE)--PWNHealth, a leading provider of healthcare diagnostic testing enablement solutions, announced today that it has received a significant growth investment led by Spectrum Equity, . . .
Posted on 9/16/20
Rectangle Health and ProSites Partner
Rectangle Health and ProSites announced a new partnership today to help dental and medical practices integrate secure and comprehensive payment solutions into their websites.Rectangle Health's patented . . .
Posted on 9/16/20
Conversion Labs Closes $3.5 Million Equity Investment
Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, has completed its previously announced equity investment by a select group
Posted on 9/16/20
Should You Buy Gilead Now That It's Acquiring Immunomedics?
Many investors have long hoped that Gilead Sciences (NASDAQ:GILD) would use its massive cash stockpile to fund a major acquisition. That hope is now being fulfilled.Gilead . . .
Posted on 9/16/20
Germany Awards $743 Million to BioNTech and CureVac for Coronavirus Vaccine Development
To accelerate COVID-19 vaccine development and boost vaccine manufacturing capacity within its borders, the German Federal Ministry of Education and Research is awarding BioNTech (NASDAQ:BNTX) and . . .
Posted on 9/16/20
The Bristol-Myers CVR Is Worth $7.83
SummaryBristol-Myers disclosed some market moving information on a Citigroup call.We are getting close to the deadline for Liso-cel and the manufacturing facilities haven't been inspected yet.Investors . . .
Posted on 9/15/20
Siemens Healthineers Collaboraes With CDC
TARRYTOWN, N.Y.--(BUSINESS WIRE)--Siemens Healthineers announced today a collaboration with the U.S. Centers for Disease Control and Prevention (CDC) and the JRC of the European Commission on a . . .
Posted on 9/15/20
Mylan and Pfizer Receive European Commission Approval for Proposed Combination of Mylan and Upjohn
Mylan (NASDAQ: MYL) and Pfizer Inc. (NYSE: PFE) today announced that the companies have received final approval from the European Commission (EC) for the proposed combination . . .
Posted on 9/15/20
Johnson & Johnson: Pick It In The Absence Of News
SummaryQ2 is seen by company's management as the worst quarter as the things started to improve at the end of the quarter.COVID-19 vaccine is planned to . . .
Posted on 9/15/20
Pfizer Says It Could Know If Its COVID-19 Vaccine Candidate Works in October
Pfizer (NYSE:PFE) is conducting one of the most advanced trials of a vaccine for COVID-19, and CEO Albert Bourla told an interviewer on Sunday that the . . .
Posted on 9/15/20
Merck Inks Multibillion-Dollar Deal With Seattle Genetics, Including Equity
Merck & Co (NYSE:MRK) and Seattle Genetics (NASDAQ:SGEN) have agreed to terms in a licensing and equity-investment deal that could be worth $4.2 billion to Seattle . . .
Posted on 9/14/20
Neogene Therapeutics Raises $110 Million Series A Financing
Neogene Therapeutics, Inc., a pre-clinical stage biotechnology company pioneering a new class of fully personalized neo-antigen T cell therapies to treat cancer, today announced that it . . .
Posted on 9/14/20
2020’s States that Vaccinate the Most – WalletHub Study
With multiple companies racing to develop an effective COVID-19 vaccine but 1 in 3 Americans saying they wouldn’t get vaccinated, the personal-finance website WalletHub today released . . .
Posted on 9/14/20
Pfizer and BioNTech Plan to Increase Size of Their Coronavirus Vaccine Clinical Trial
Within the next week, Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) expect to reach their goal of enrolling 30,000 participants in the phase 2/3 clinical trial testing their . . .
Posted on 9/14/20
Merck (Finally) Starts a Clinical Trial of its Coronavirus Vaccine
Multiple drugmakers are in phase 3 clinical trials for their coronavirus vaccines -- the last stage before potential approval. Meanwhile, Merck (NYSE:MRK) is just now starting . . .
Posted on 9/14/20
Gilead Sciences to Acquire Immunomedics for $21 Billion in Cash
Gilead Sciences' (NASDAQ:GILD) mission to create a better oncology portfolio took a big step forward on Sunday. The company best known for antiviral treatments made Immunomedics . . .
Posted on 9/14/20
Could Intercept Pharmaceuticals Be a Millionaire-Maker Stock?
Intercept Pharmaceuticals (NASDAQ:ICPT) is like a lot of biopharmaceutical stocks: It's not making money, but all it takes is one major drug to turn things around.Intercept, . . .
Posted on 9/13/20
Intra-Cellular Therapies Prices Public Offering of Common Stock
NEW YORK, Sept. 10, 2020 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company, today announced the pricing of its previously announced underwritten public . . .
Posted on 9/11/20
Pfizer's Latest Stealthy Move Could Help It Win the Coronavirus Vaccine Race
Pfizer (NYSE:PFE) hasn't been bashful about playing up the prospects for its coronavirus vaccine candidate, BNT162b2, co-developed with BioNTech (NASDAQ:BNTX). The company even predicted that it . . .
Posted on 9/10/20
Athenex Prices $110M Public Offering of Common Stock
BUFFALO, N.Y., Sept. 10, 2020 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies . . .
Posted on 9/10/20
NYP Hospital and The Rogosin Institute Host Virtual Symposium, Lessons Learned from COVID-19: Preparing for a Future Pandemic
NewYork-Presbyterian Hospital and The Rogosin Institute will hold their annual symposium virtually this year, with a focus on lessons learned from the COVID-19 pandemic. Attendees will . . .
New York
